Korro to Host Virtual Analyst Day on January 27, 2026
(NASDAQ:KRRO), – Program to feature presentations from the company management about KRRO-121 for the potential treatment of hyperammonemia, a leading clinical hepatologist about ammonia-driven diseases, and a caregiver sharing perspectives on living with urea cycle disorder – CAMBRIDGE, Mass., Jan. 20, 2026 (GLOBE NEWSWIRE) — Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that the […]